Sort
30,917 grants matching “tumor microenvironment”
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$473,443Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Matrix density promotes pro-tumorigenic hormone actions in breast cancer
$473,371Linda A. Schuler · University Of Wisconsin-Madison · R01 · FY2023 · CA
Matrix density promotes pro-tumorigenic hormone actions in breast cancer
$473,371Linda A. Schuler · University Of Wisconsin-Madison · R01 · FY2022 · CA
Understanding the impact of chemotherapy on breast cancer metastasis and immune function in the liver
$473,350Sandra S McAllister · Brigham And Women'S Hospital · R01 · FY2024 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$473,262Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2023 · CA
Transcriptomic origins of cancer
$473,235Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
$473,214Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells
$473,214Qing Yi · Methodist Hospital Research Institute · R01 · FY2023 · CA
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$473,165Martin G Pomper · Johns Hopkins University · R01 · FY2020 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$473,142Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2021 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$473,142Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2020 · CA
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
$473,142Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2019 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$473,084David G Denardo · Washington University · R01 · FY2025 · CA
Mechanisms of Variant ER-alpha Function in Breast Cancer
$473,080Amy Fowler · University Of Wisconsin-Madison · R01 · FY2024 · CA
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic Cancer
$473,069Chandan Guha · Albert Einstein College Of Medicine · R01 · FY2023 · CA
Project 1: Deciphering the Dynamic Evolution of the Tumor-Neural Interface
$473,047Nathalie Yr Agar · Massachusetts Institute Of Technology · U54 · FY2023 · CA
The identification of human hepatocellular carcinoma metastasis genes
$473,003Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
TBEL Project 2
$472,982Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm
$472,960Mohammed Noor Tantawy · Vanderbilt University Medical Center · R21 · FY2021 · CA
Genetic Alterations That Confer High Risk to Oral Premalignant Lesions
$472,892Carlos Caulin · University Of Arizona · R01 · FY2023 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$472,806Elias Sayour · University Of Florida · R37 · FY2021 · CA
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$472,799Jlenia Guarnerio · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Therapeutic Targeting of Macrophage PI3Kgamma in HNSCC
$472,763Judith A. Varner · University Of California, San Diego · R01 · FY2021 · CA
Astrocyte and microglial cell state transitions in response to activation of the immune system in Alzheimer's disease
$472,750James R. Heath · Institute For Systems Biology · U01 · FY2020 · CA
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
$472,698Tony R. Hunter · Salk Institute For Biological Studies · P01 · FY2024 · CA